It requires a tailored plan, nutritional support, and regular follow-up to ensure safety and long-term success
They may recommend adjusting your dose, trying anti-nausea medication, or switching to a different medication
The NHS says tirzepatide (Mounjaro) will only be prescribed to certain people with a BMI over 40 - or 37.5 in patients from a minority ethnic background - with at least four out of five of the following health problems linked to obesity: Type 2 diabetes High blood pressure Heart and vascular disease High cholesterol Obstructive sleep apnoea Semaglutide (Wegovy) can be prescribed from a weight loss specialist to adults with a BMI of at least 35 and have at least one pre-existing weight-related health condition, such as high blood pressure.
The data confirms that for Type 2 diabetes patients on basal insulin, CGM technology isn't just a "nice-to-have"it's a critical tool for improving HbA1c and increasing Time in Range (TIR)
However, the SUSTAIN clinical trials of Ozempic (semaglutide) showed that in addition to blood sugar control, the drug caused weight loss in participants with Type 2 diabetes and obesity
